ArticleInvestigational new drugs2011

Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancer.

Shun-Lai Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.